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Several studies have been conducted that link poor control of hemoglobin A1c (HbA1c) 
to an increased risk of heart disease. However, there are limited published studies that 
link HbA1c and heart disease based on ethnicity and gender. To address this gap in 
literature, the purpose of this study was to assess the association between HbA1c and 
heart disease in African American males (aged 30–64 years old) while controlling for 
education, income, and access to care. The research questions were focused on 
establishing an association between HbA1c values and heart disease in African American 
men through the lens of the health belief model. Secondary data (N=243) were used from 
the Nutritional Health and Examination Survey (2011-2016) and analyzed.  . Chi-square 
analysis and multiple logistic regression were conducted to test for an association 
between HbA1c and heart disease in men aged 30–64 years old. The variables of Hba1c 
values, various forms of heart disease, and stroke were tested while controlling for age, 
education, income, and access to care. Key results indicated no association between 
HbA1c and heart disease; yet, it is recommended that future research on the topic should 
include a larger sample of those with heart disease, from other sources, to better assess 
the outcome. The positive social change implications include the addition of research 
related to gender-specific outcomes and ethnicity-related risk between HbA1c and heart 
disease, which can be used to achieve better disease management and provide educational 
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Chapter 1: Introduction to the Study 
Introduction 
In this quantitative study, I examined which factors increase the diagnosis of heart 
disease in African American males aged 30–64 years old. There is ample knowledge that 
diabetes can lead to heart disease; however, there is no published information on this 
association by ethnicity and gender. According to the American Heart Association 
(American Heart Association [AHA], 2017a), heart disease is the leading cause of death 
in the United States. African Americans are more likely to die from heart disease due to 
social and environmental risk factors such as stress, diet, and exercise, which present 
challenges for healthy lifestyles and disease prevention (AHA, 2017a). The overall 
significance of this study lies in the results which will allow diabetics the opportunity to 
make lifestyle changes and be proactive in their own health prior to the development of 
cardiac disease. The positive social change implications of this study include the 
addition of research related to gender-specific outcomes and ethnicity-related risks 
between hemoglobin A1c (HbA1c) and heart disease, which can be used to achieve 
better disease management and provide educational opportunities for diabetic African-
American men. Chapter 1 will include the following sections: background of the 
research problem, the problem statement to address the lack of research by ethnicity and 
gender, the purpose of the study, research questions and hypotheses, theoretical 
foundation, the nature of the study, definitions, assumptions, scopes and delimitations, 




Diabetes is a chronic condition that affects multiple organs and organ systems 
within the body, including the cardiovascular system (Mayo Clinic, 2018c). 
Characterized by a chronically high glucose level in the blood, diabetes causes plaque to 
build up in the heart, leading to an increase in cholesterol (Mayo Clinic, 2018c). This 
plaque buildup causes a reduction in blood flow, which can lead to high blood pressure, 
heart attacks, stroke, and even death (Boehringer Ingelheim Pharmaceuticals, 2016). 
According to Traylor et al. (2010), patient ethnicity is associated with risk factors and 
treatment options in both diabetes and heart disease. However, further research is needed 
to identify potential disparities in HbA1c values and the development of heart disease 
(Jeppesen, Hein, Suadicani, & Gyntelberg, 1998; Traylor et al., 2010).  
It is unknown whether early intervention, from the time of a diabetes diagnosis, 
can prevent heart disease. Although researchers agree that diabetes is a risk factor for 
heart disease, enough data does not exist to support recommendations to change current 
practice in the treatment of diabetes to help prevent the development of heart disease by 
ethnicity (Rana, Liu, Moffet, Jaffe, & Karter, 2016). Both the AHA and the American 
Diabetes Association (ADA) agree that lifestyle and medical interventions can delay or 
reduce the development of heart disease, allowing diabetics to live longer, healthier lives 
(Buse et al., 2007). One of the main questions being asked by the research community 
and medical providers is why African Americans are not receiving recommended 
treatments (Vulic, Lee, Dede, Lopez, & Wong, 2010). Barriers to treatment options lead 
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to suboptimal control of heart disease risk factors and HbA1c target goals (Malik, Lopez, 
Chen, Wu, & Wong, 2007).  
There are few extant research studies that have used prediction models to assess 
various forms of heart disease and diabetes to prevent death and improve quality of life 
(McEwen et al., 2012). In this study, I focused solely on coronary heart disease (CHD), 
hypertension (HTN), high cholesterol, heart attack, and stroke and how these forms of 
heart disease are associated with HbA1c levels in African American men while 
controlling for age, education, income, and access to care. Whiteley, Padmanabhan, Hole, 
and Isles (2005) suggested that diabetes risk factors be treated as aggressively as heart 
disease risk factors. This is further supported by the Framingham Risk Score, which 
predicts heart disease and has shown multiple risk factors between diabetes and 
cardiovascular disease (CVD; Whiteley et al., 2005). When adding in HbA1c to the risk 
factors identified by the Framingham Risk Score, a statistically significant improvement 
was seen in men that predicted an increase in risk for development of heart disease 
(Simmons et al., 2008). When diabetes was identified as a risk factor within the first 10 
years of diagnosis, a significant improvement was seen in all-cause mortality in men 
(Wannamethee, Shaper, Whincup, Lennon, & Sattar, 2011).   
In 2005, researchers started asking whether diabetes should be considered a risk 
factor for CHD (Muntner et al., 2005; Selvin et al., 2005; Whiteley et al., 2005). In 2010, 
researchers examined the Nutritional Health and Examination Survey (NHANES) from 
2005–2006 and concluded that efforts were still needed to implement guidelines to 
adequately treat heart disease risk factors including diabetes (Vulic et al., 2010). Further 
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research in 2010 corroborated these findings and added that in the ADA’s view, evidence 
exists to support an association with higher HbA1c levels and heart disease (Matsushita 
et al., 2010; Selvin et al., 2010). By 2015, researchers were publishing data to support the 
use of drug therapy to eliminate heart disease risk factors found in Type 2 diabetics 
(Strang et al., 2015). This was an important milestone in research because those with 
diabetes were not meeting risk factor controls to prevent the development of heart disease 
(Mark et al., 2015). By 2015, the AHA and the ADA published an update on the most 
recent evidence to support the need for new diabetic guidelines to manage diabetes and 
prevent adverse outcomes related to poor glycemic control (Fox et al., 2015). These 
outcomes included blood pressure management, cholesterol management, and glucose 
control (Fox et al., 2015). 
 Although there is some ethnicity-based research on the relationship between 
diabetes and genetics, there is limited published data on diabetes and heart disease by 
ethnicity. India, known as the diabetes capital of the world, has established a phenotype 
that shows high insulin resistance in individuals with Type 2 diabetes (T2DM; Raj, 
Bhatti, Badada, & Ramteke, 2015). This phenotype in T2DM leads to low insulin 
sensitivity, insulin resistance, and higher levels of coronary artery disease (Babikr, 
Alshahrani, Hamid, Abdelraheem, & Shalayel, 2016). Longitudinal studies in adults have 
shown that early diabetic interventions do reduce cardiovascular complications and 
mortality (Babikr et al., 2016). In addition, in a study of an indigenous Australian 
community, researchers identified individuals at substantial risk for developing diabetes 
and showed those with and without diabetes may already have early onset heart disease 
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based on HbA1c values (Arnold, Hoy, Sharma, & Wang, 2016). The results of my study 
might provide early identification of at-risk diabetic individuals and might produce 
evidence that could be used to decrease the chance of serious heart disease in the African 
American male population.  
Problem Statement 
The problem I addressed in this study was the lack of research on the association 
between HbA1c and heart disease in the male African American population while 
controlling for age, education, income, and access to care. Disparities in HbA1c have 
been shown between African Americans, Asian Americans, and Latinos (Kirk et al., 
2006). Researchers have also suggested that HbA1c control may be poorer among 
African American populations when compared to Whites, related to lack of preventive 
care (Kirk et al., 2006). The results of this study add to the extant literature with 
assessments of HbA1c levels and the risk of developing heart disease based off HbA1c 
levels in the male African American population, a topic area that has not been covered in 
previous research.  
Heart disease accounts for 31% of deaths worldwide (Cavero-Redondo, Peleteiro, 
Alvarez-Bueno, Rodriguez-Artalejo & Martinez-Vizcaino, 2017; World Health 
Organization [WHO], 2017) and is the leading cause of mortality in Type 2 diabetics 
(Banovic et al., 2016). Diabetes is known to cause plaque to build up in the heart, which 
allows cholesterol to increase (AHA, 2017a). This build-up can then cause a reduction in 
blood flow leading to CHD, high blood pressure, heart attacks, stroke, and even death 
(AHA, 2017a; National Institute of Diabetes and Digestive and Kidney Diseases 
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[NIDDK], 2017a). According to Arnold et al. (2016), individuals with diabetes have 
higher rates of vascular disease than nondiabetics. Therefore, understanding the 
characteristics of a diabetes diagnosis is essential to establishing therapeutic goals to 
prevent CVD. With this study, I aimed to determine whether there is an association 
between HbA1c and heart disease in the male African American population aged 30–64 
years old. I chose the age of 30 years old to eliminate the chance of including only Type 
1 or juvenile diabetics, and I chose the age 64 years old because there is a greater chance 
of preexisting cardiovascular complications by this age. 
Purpose of the Study 
The purpose of this quantitative study was to assess for an association between 
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in 
known diabetic African American men aged 30–64 years old. Covariates included: 
education, income, and access to care. My intent with this study was to explore the 
association between heart disease and HbA1c in African American men with diabetes. I 
wanted to also test for an association between HbA1c values and heart disease while 
controlling for education, income, and access to care. This research was limited in nature 
to diabetic African American men age 30-64.  
Research Questions and Hypotheses 
 
The study was limited to African American men diagnosed with diabetes and 
aged 30–64 years old. I used a research strategy incorporating chi-square analysis, and 
multiple logistic regression to test the following research questions:  
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Research Question 1: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old?  
H01: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
Ha1: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
Research Question 2: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30-64 years old after 
controlling for education, income, and access to care?  
H02: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care. 
Ha2: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care.  
Theoretical Framework 
In this study, I used the health belief model (HBM) as the theoretical framework 
to describe the association between HbA1c and cardiac disease outcomes. The HBM is a 
theory based on health behavior and focuses on four principal areas: the severity of the 
illness, how susceptible a person is to an illness, the benefits of preventative care, and 
actual or potential barriers that keep an individual from acting to prevent disease 
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progression (Current, 2012). This model can also be used to help individuals with the 
perception of their beliefs in relation to their behaviors (Current, 2012).  
In this study, I used the HBM to address health concerns, such as how HbA1c 
contributes to heart disease in the African American male population. By understanding 
the relationship between diabetic control and the impact unmanaged diabetes has on heart 
disease, the quality of life in this population can be improved. The HBM can be used to 
design both short and long-term interventions based on the study results. In new on-set 
diabetes, short and long-term interventions can include medication management, and in 
known diabetics, this can include preventative care to delay further development of heart 
disease. In this study, I gathered the necessary information to perform a needs assessment 
of the population at risk. The interpretation of these results will convey when individuals 
are at an increased risk for heart disease based on HbA1c levels, age, education, income, 
and access to care (Rural Health Information Hub, 2018). When used appropriately, the 
HBM will provide an organized assessment of the risks related to increased HbA1c and 
heart disease outcomes (Tarkang & Zotor, 2015).  
By identifying those most at risk and understanding the relationship between 
HbA1c and the development of heart disease, a tool is created that encompasses a 
detailed plan to adopt health promotion and disease prevention programs. In the African 
American male population, barriers to care include lack of knowledge of the disease 
process, lack of time, and lack of support (Crabtree et al., 2015). In the Crabtree et al. 
(2015) study, men expressed a desire for diabetic interventions to improve self-
management skills and diabetes-related health outcomes. Additionally, free, convenient, 
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culturally sensitive and gender appropriate programs were requested (Hurt, Seawell, & 
O’Conner, 2015). Social change will stem from adding to the current research on this 
topic by identifying ethnic risks related to HbA1c and heart disease as well as creating a 
plan of action to improve the self-management skills and diabetic-related health 
outcomes in this population, leading to better disease management and educational 
opportunities. 
Nature of the Study 
The nature of this study was a quantitative design based on an analysis of 
secondary data. The independent variable was HBA1c, and the dependent variable was 
heart disease. With the results of this study, I aimed to identify those at high risk of heart 
disease based on HbA1c values, using a multiple logistic regression model. Sample data 
were grouped into age categories, which were used to define the sampling framework. 
HbA1c levels were obtained from NHANES and analyzed based on recommended 
guidelines from the Mayo Clinic. I collected the data from the NHANES 2011–2016 after 
receiving Walden University Institutional Review Board (IRB) approval.  
Definitions of Terms 
Access to care: Having a usual source of care (Spatz, Ross, Desai, Canavan, & 
Krumholz, 2010) through health insurance. This can be via private insurance, Medicare, 
Medicaid, Military health care, state-sponsored health plan, other government insurance, 
or a single service plan (Centers for Disease Control and Prevention [CDC], 2015b).  
Cardiovascular disease (CVD): Also known as heart disease, CVD is a condition 
in which blood vessels narrow and block vessels in the heart (Mayo Clinic, 2018b). This 
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can then lead to heart attacks, chest pain, or stroke (Mayo Clinic, 2018b). In addition, 
CVD is grouped into disorders to include peripheral artery disease, peripheral vascular 
disease, diseases of the heart and heart muscle, HTN, stroke, heart failure, and coronary 
heart disease (WHO, n.d.). For this study, CVD was defined as having a history of HTN, 
heart attack, or stroke.  
Coronary heart disease (CHD): Also known as coronary artery disease, CHD is 
the formation of plaque, or a fatty substance, that builds up on the walls of coronary 
arteries leading to atherosclerosis or the hardening of the artery walls (National Heart, 
Lung, and Blood Institute, n.d.). If a piece of this plaque breaks off a clot can occur 
(AHA, 2017a). Another consequence of CHD is heart attack or stroke (AHA, 2017a; 
National Heart, Lung, and Blood Institute, n.d.).  
Diabetes: A disease that occurs that keeps your blood glucose (i.e., blood sugar) 
to high, having too much blood glucose can lead to chronic health conditions (NIDDK, 
2016). These health conditions can cause heart disease, blindness, renal disease, and 
peripheral vascular disease leading to the loss of limbs (CDC, n.d.).  
Glycated hemoglobin (HbA1c): The level of sugar in your body over a 2- to 3-
month time (ADA, 2014) and helps to determine the amount of hemoglobin that is 
covered with sugar (Mayo Clinic. 2018a). This is an important number used to manage 
diabetes (Diabetes CO UK, 2018). The higher this number, the greater the risk becomes 
of developing diabetic complications (Diabetes CO UK, 2018). The recommended 
HbA1c level is different by organization, and the patient’s physician will determine what 
is appropriate for an individual based on other health conditions. Currently, the ADA 
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recommends an HbA1c of 7% or less (ADA, 2014). Those between 5.7%–6.4% are 
prediabetic, and those with HbA1c over 6% should be considered high risk for 
developing diabetes (ADA, 2018). Adults with diabetes are more likely to develop heart 
disease and die from a heart attack or stroke at a younger age than those without the 
disease (NIDDK, 2017).  
Hypertension (HTN): A disease where the force of blood going through your 
blood vessels is consistently too high; more than half of adults have high blood pressure 
(AHA, 2017b). For many, there are no symptoms, but if not treated an individual can 
suffer a heart attack, stroke, or other health complications (AHA, 2017a). Normal blood 
pressure is less than 120/80, elevated is systolic between 120–129 and diastolic less than 
80, Stage 1 is systolic 130–139 or diastolic 80–89, Stage 2 is systolic of 140 or higher or 
diastolic of 90 or higher (American College of Cardiology Foundation, 2018).  
Type 2 Diabetes (T2D): A disease where your body is unable to make or use 
insulin; this type of diabetes is often seen in middle-aged and older individuals (NIDDK, 
2016). This type of diabetes is also called insulin resistant diabetes and is the most 
common form of diabetes (NIDDK, 2016). This type of diabetes keeps your blood sugars 
out of the normal range (ADA, n.d.b.). Your body either resists or does not make enough 
insulin to regulate the amount of sugar found in your bloodstream (Mayo Clinic, 2018c). 
Assumptions 
I made several assumptions in this study. One of them was that the NHANES 
database adequately represents the African American male population in its entirety. 
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Another assumption was that HbA1c levels were reported correctly and that there were 
no lab errors in the processing of the specimens. I also assumed that those reporting heart 
disease understood the working definition of the term and the subsequent cardiac diseases 
that were under the umbrella of that definition. Finally, it was assumed that the secondary 
data used were accurately collected and reported.  
Scope and Delimitations  
In this study, I evaluated the association between HbA1c and reported 
cardiovascular events in African American men. This study was conducted using data 
from NHANES 2011–2016. By evaluating multiple years, the sample size is more likely 
to be representative of the population being studied. I focused on men aged 30 to 64 years 
of age. The focus on men over age 30 was to eliminate most Type 1 diabetics, and those 
over age 64 was to eliminate men that may have suffered from more serious cardiac 
events. The African American community is at high risk for diabetes and subsequent 
cardiovascular events (George, Selvin, Pankow, Windham, & Folsom, 2017; Selvin et al., 
2016). I used the HBM as the theoretical framework.  
Limitations  
I identified several limitations in this study. One of the limitations related to the 
amount of data that were available. Additional limitations centered on the lack of 
available data that focused solely on African American men versus all men or all African 
Americans as a whole. Available data were grouped into categories that did not separate 
out ethnicity or disease burden by disease type. To clarify, there have been cardiovascular 
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studies that focused on men but not just on African American men or a single ethnicity. 
The same is held true when researching diabetic outcomes in African American 
populations. The extant research has often focused on the entire ethnic population and not 
separated by gender. Thus, the data does not truly capture the association of disease by 
ethnicity and gender. Finally, a limitation was placed on knowing whether the participant 
was a Type 1 or Type 2 diabetic because HbA1c values do not clearly define the type of 
diabetic an individual is.  
Significance of the Study  
The results of this study can be used to identify those at substantial risk for heart 
disease and were aimed at identifying heart disease risk based on HbA1c values. I 
conducted this quantitative analysis to determine whether there is an association between 
HbA1c values and heart disease and adjusted for age to assess which group is most at risk 
for heart disease based on HbA1c values. By including HbA1c values into routine 
physical exams, elevated HbA1c levels can be monitored for the development of heart 
disease. These rising values not only address the potential risk of developing diabetes but 
also the potential risk for developing heart disease. With less than half of all adults in the 
United States meeting guidelines for diabetic care, the ADA and AHA have jointly 
established new recommended guidelines for the prevention and treatment of diabetes to 
reduce microvascular complications, which lead to adverse heart disease (Fox et al., 
2015). These recommendations include risk factor management and screening for CVD 
complications in all populations (Fox et al., 2015). The results of this study provide the 
data needed to support the findings of the ADA and AHA in terms of glucose 
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management and prevention of CVD outcomes. Social change implications include the 
addition of research related to gender-specific outcomes and ethnicity-related risk 
between HbA1c and heart disease, leading to better disease management and educational 
opportunities. The findings of this study provide evidence that HbA1c levels may predict 
heart disease and allow for early intervention by healthcare providers, which could come 
through lifestyle changes or medication management.  
Summary and Conclusion 
In this chapter, I reviewed the need for further research on the association 
between HbA1c and heart disease in diabetic African American men. Several studies 
have been conducted to link poor HbA1c control to heart disease; yet, there are few, if 
any, published research articles that link HbA1c values and heart disease by ethnicity. In 
this chapter, I previewed the background on diabetes and how diabetes affects the 
cardiovascular system. The main problem statement was addressed and described my 
focus on the disparities in relation to diabetes risk factors and heart disease outcomes in 
this study. The purpose of this quantitative study was to determine the association 
between HbA1c and heart disease in the African American population. Research 
questions were provided along with the corresponding null and alternative hypotheses. In 
addition, I identified the theoretical framework as the HBM, the definitions and 
assumptions, and the study limitations. This chapter concluded with the significance of 
the study and the implications for positive social change. In Chapter 2, I will address gaps 
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in the literature about the association between HbA1c, heart disease, and diabetic African 
American males.   
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Chapter 2: Literature Review 
Introduction 
Diabetes is a chronic medical condition that affects 4.9 million African Americans 
(ADA, n.d.a). Additionally, the African-American population is 1.7 times more likely to 
develop diabetes than their White counterparts (U.S. Department of Health and Human 
Services Office of Minority Health [DHHS], 2016). Since 1994, the percentage of 
African Americans with diabetes has steadily increased from 9.1% to 13.4% in 2014 
(DHHS, 2016). Diabetes is a known precursor to heart disease and is strongly associated 
with the development of heart disease (Xanthakis et al., 2015). Research has also shown 
that heart disease can develop from diabetic complications and is ranked as a top cause of 
mortality in American people (AHA, 2017a) with African Americans consistently 
ranking as the highest risk compared to other ethnicities (Lee et al., 2013). With this 
study, I aimed to identify an association between heart disease risk based on age and 
HbA1c levels in African American men.  
According to current publications, there is a lack of research on the association 
between diabetes and CVD by race and gender, and there are no published studies that 
address gender and CVD in African American men (George et al., 2017; Regensteiner et 
al., 2015; Xanthakis et al., 2015). Further research is needed to understand the 
relationship between high blood sugars (i.e., HbA1c) and heart disease to establish 
whether there is a need for intervention using medication therapy (George et al., 2017). 
Additionally, the current research has only estimated a greater relative risk for CVD 
development among White woman with diabetes, creating the potential for research bias 
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by ignoring competing risk factors (George et al., 2017; Xanthakis et al., 2015). These 
risks may prove to be modifiable if the standard of practice for diabetic patients changes 
to encompass pretreatment of heart disease.  
In this chapter, I cover historical and current literature on the association between 
HbA1c and CVD; the strategy used to conduct the literature review; and go into more 
detail about the HBM, being used as the theoretical framework. Key concepts and the 
pathophysiology of diabetes and heart disease are explored. The chapter concludes with 
an explanation of why the study should be conducted. The results of this study provide 
information that can be used to establish clinical guidelines to assist in identifying risk 
factors that lead to major heart disease in diabetics and help to decrease the number of 
years lost related to disease manifestation.  
Early intervention, from the time of a diabetes diagnosis, may prevent heart 
disease (Tuso, 2014). In this study, I focused on the lack of research that has been 
conducted on the association between heart disease and HbA1c levels in the non-
Hispanic Black male community (see Gray et al., 2016; Jeppesen et al., 1998; Traylor et 
al., 2010), and while it is agreed upon that diabetes is a risk factor for heart disease, there 
are no published research studies that focus on African American men and how HbA1c is 
associated with heart disease. These studies are needed to prevent death and improve the 
quality of life of individual ethnicities to include Hispanic, African American, and 
Asian/Pacific Islanders (McEwen et al., 2012).  
According to Traylor et al. (2010), patient ethnicity is associated with diabetes 
risk factors and treatment outcomes. These diabetic risk factors influence cardiac risk 
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factors when associated with diabetic treatment options (Traylor et al., 2010). Both the 
AHA and the ADA agree that lifestyle and medical interventions can delay or reduce the 
development of heart disease, allowing diabetics to live longer, healthier lives (AHA, 
2017a; Buse et al., 2007). When heart disease is treated as a risk factor in diabetes and 
within the first 10 years of a diabetes diagnosis, a significant improvement was seen in 
blood glucose levels (p < .001) and in HbA1c levels (p = .006; Wannamethee et al., 
2011). In the United Kingdom Prospective Diabetes Study (UKPDS), for every 
percentage point reduction, heart disease risk decreased 24% (Kirk et al., 2006; Wenzel 
& Unger, 2016). These risk factors fall in line with the ADA 2017 Standards of Care 
which identified the need to promote health and reduce disparities in populations with 
diabetes. Standard 9 of the ADA 2017 Standards of Care identifies the fact that control of 
HbA1c has led to a reduction of heart disease in diabetic patients (ADA, 2017a). Overall, 
there is sufficient data that supports a correlation between diabetes and heart disease 
(Selvin et al., 2005; Traylor et al., 2010). However, there are not enough studies that 
represent individual ethnic populations in relation to diabetes and heart disease. 
According to Selvin et al. (2016), little data exists on HbA1c and heart disease outcomes 
in Blacks. There is also little known about gender differences in African Americans, and 
there are no studies that test the interaction of diabetes and heart disease outcomes in 
African Americans (George et al., 2017). In this study, I focused on a gap in the literature 
regarding data to support the relationship between HbA1c and heart disease in the male 
African American population. As stated by Thorpe et al. (2017), targeting intervention 
strategies and the identification of preventable or modifiable risk factors is consistent 
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with health disparities research. For this reason, I focused solely on the male, African 
American population adding to the research that focuses on the health and functional 
status of this population.   
Literature Search Strategy 
I conducted the literature review using multiple databases, including EBSCOhost, 
Science Direct, ProQuest, PubMed, Ovid, CINAHL, the CDC, Circulation, and Sage 
Journals. Keywords used to locate published research were diabetes, Type 2 diabetes, 
glycated hemoglobin A1c, HbA1c, hemoglobin A1c, cardiovascular disease, heart 
disease, Black, African American, and non-Hispanic Black. The literature review 
included sources published from 2005–2018. I used articles published before 2005 as 
historical documents and reference articles for additional literature searches, 
methodologies, or keywords.  
Theoretical Foundation 
In this study, I used the HBM as the theoretical framework to analyze the 
relationship between HbA1c and heart disease. In this section, I will discuss the 
theoretical propositions for this theory and how it has been previously applied to similar 
studies. This section is organized into the following subsections: overview, previous 
studies that used the HBM, and other theories that could have been used in this project.  
Overview 
 
The HBM was developed in the 1950s to understand why individuals did not 
accept disease prevention or screening tests to detect asymptomatic disease (Ebomoyi, 
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2013; Webster & Heeley, 2010). One of the constructs of this theory is perception, which 
is influenced by personal factors to include education and parental influence (Ebomoyi, 
2013). Two other components of this theory focus on an individual’s desire to avoid 
illness and the belief that preventive care can stop illness from occurring (Webster & 
Heeley, 2010). This component includes the self-management of diabetes and adhering to 
diet and exercise regimes to control HbA1c values. This model has been used in previous 
CVD studies to identify perceived susceptibility as the main factor for compliance. In 
addition, by organizing a family history tree with chronic medical conditions, the threat 
of a chronic health condition becomes visual for the individual (Ebomoyi, 2013). This 
then leads to cues for action, because the perceived seriousness of disease has the greatest 
impact on health belief (Cao, Chen, & Wang, 2014).  
The results of this study provide key information on how the HBM can be used to 
identify personal and familial risk for the development of heart disease in diabetic 
individuals. The HBM can then be used to design both short and long-term interventions 
based on the study results, which adds to the foundation of the HBM, in which perceived 
susceptibility is validated by the data obtained. The use of HBM in this manner allows for 
calculation of the perceived severity of disease complications, when compared to HbA1c 
values and heart disease outcomes based on age, education, income, and access to care 









The HBM is not typically used as a primary model in the analysis of secondary 
data. While theories, such as the grounded theory, Orem’s theory of self-care, the 
explanatory theory, and the change theory, were also explored, I chose the HBM based 
on previous research studies that utilized this theory. Most of the studies that employed 
the HBM focused on the process of disease. In a review of studies, the strength of 
association between the perception of disease risk and the factors related to risk severity 
were explored (Brewer, Chapman, Gibbons, Gerrard, & McCail, 2007). These studies 
showed a similar consistency, and strength of association, between the risk of disease and 
behavior. This review also showed how applying the HBM to my research may improve 
the ability to predict the severity of disease and identified perceived susceptibility. The 
HBM will enable researchers to develop a method that shows how heart disease is 
associated with HbA1c in diabetics.  
 When combining the term HBM and secondary data, I found additional 
information in the literature to support the role of the HBM and diabetes and the HBM 
and heart disease. A common similarity between the extant studies was a need for 
culturally sensitive information related to the African American male population 
(Crabtree et al., 2015; Hurt et al., 2015; Tarkang & Zotor, 2015). This was noted in 
several research articles that explored compliance with disease management and the 
relation of statistical data to outcome driven incentives.  
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In this study, my use of HBM helped establish whether there was an association 
between HbA1c and heart disease when accounting for age, education, income, and 
access to care. This model allows for intervention measures and education to be provided 
to this population to deter from the beliefs that men should be strong, avoid vulnerability, 
and that “black men [are] diabetic” (Hurt et al., 2015, p. 5) By incorporating sensitivity 
training and having other African American mentors as role models, the collected data 
assists in changing the beliefs that diabetes is a disease that is expected. Instead, men 
were taught that to maintain the role of provider and head of household, preventive 
measures must be taken to decrease the chance of disease progression. Such information 
needs to be given free of charge and at convenient times for this population and be 
presented by someone who understands Black culture. This will ensure that the 
individuals are spoken to appropriately and not spoken down to and allow for culturally 
sensitive and gender appropriate interventions (Hurt et al., 2015). These interventions 
will help displace myths about diabetes that include how diabetes is developed, what 
foods cause diabetes, and the seriousness of diabetes (ADA, 2017b). Each of these topics 
falls into the belief of how the disease progresses and is treated based on the results of 
this data.  
Literature Review Related to Key Concepts  
Pathophysiology 
Diabetes is a risk factor for CVD, with HbA1c also being a predictable risk factor 
for cardiovascular mortality (Cavero-Redondo, et al., 2017; Ford & DeStefano, 1991). 
Heart disease accounts for 31% of deaths worldwide (Cavero-Redondo, et al., 2017; 
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WHO, 2017) and is the leading cause of mortality in T2DM (Banovic et al., 2016). The 
evidence to support the dominant contributor to hyperglycemia in patients with HbA1c < 
8.5%, focuses on postprandial levels, while fasting glucose levels are a major contributor 
to higher HbA1c levels (Borg et al., 2010). Fasting glucose levels are the dominant 
contributor to HbA1c levels in diabetics with glycohemoglobin levels > 8.5% (Borg et 
al., 2010; Moher, Liberati, Tetziaff, & Altman, 2009). Additionally, higher levels of 
glycohemoglobin were significantly associated with higher hazard ratios for 
cardiovascular mortality (Cavero-Redondo et al., 2017). Thus, glycohemoglobin (i.e., 
HbA1c) has been shown to be a stronger predictor of heart disease than fasting glucose 
(Cederberg et al., 2010). Several epidemiological studies have also shown an association 
between 2-hour post-oral glucose tolerance tests and increased mortality and heart 
disease (Borg et al., 2010). Yet, HbA1c correlated with average blood glucose levels is 
the diagnostic standard introduced by the World Health Association in 2011 (Borg et al., 
2010; Gray et al., 2016).  
Diabetic Complications 
Glycated hemoglobin (HbA1c) is an indicator of the average blood glucose over a 
2-3-month time frame and is the recommended method for a diagnosis of diabetes (ADA, 
2017a; McNeely et al., 2009; WHO, 2011). These high blood glucose levels can damage 
the heart and blood vessels (NIDDK, n.d.). However, HbA1c levels can be used to create 
an algorithm for cardiovascular risk using age, gender, smoking status, blood pressure, 
and cholesterol levels and determining variables (Cavero-Redondo et al., 2017). Yet, 
there are no large studies examining HbA1c and cardiac disease in ethnic minority 
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populations to support this (Kirk et al., 2006; McNeely et al., 2009; Thorpe Jr.. et al., 
2017).  
Prior studies revealed how diabetic complications affect the African American 
population. These diabetic complications are experienced at a higher rate in African 
Americans leading to a 46% higher chance of developing renal disease and kidney failure 
resulting in dialysis than non-Hispanic Whites (Kirk et al., 2006). Additionally, older 
African Americans consistently have a higher prevalence of chronic conditions than older 
White adults with diabetes, heart disease, and stroke being the highest cause of disability 
in African American men (Thorpe Jr. et al., 2017). Disparities in HbA1c have been 
shown between African Americans, Asians, and Latinos and literature has suggested that 
HbA1c control may be poorer among minority populations, with access to quality care 
suggesting less optimal diabetic care and subsequent diseases, related to lack of 
preventive care (Kirk et al., 2006). Additionally, there has not been a study that focuses 
on HbA1c and diabetics in African American populations (Kirk et al., 2006; McNeely et 
al., 2009; Thorpe Jr. et al., 2017). Kirk et al. (2006) conducted the first meta-analysis 
showing that African Americans have a higher elevated HbA1c compared to non-
Hispanic whites with an effect size difference of ~0.65% (Kirk et al., p. 4, 2006). Kirk et 
al. then concludes that further research is needed to understand why African Americans 
have poorer glycemic control than non-Hispanic Whites, and to further identify 
interventions that can be made to prevent cardiovascular disease. Concluding that there is 
little research on the association between diabetes and disabilities related to diabetes in 




The optimal range for low mortality between HbA1c and heart disease is an 
HbA1c range from 6-8% (Cavero-Redondo et al., 2017). Low mortality, as defined by the 
number of life-years lost, is an HbA1c in this range, factoring in length of disease, 
treatment of disease, and adherence to treatment (The Emerging Risk Factor 
Collaboration, 2011). This then shows that the number of life-years lost can be decreased 
from 3-4 years by age 65, 2-2.5 years by age 75, and 1-1.5 years by 85 (The Emerging 
Risk Factor Collaboration, 2011). There is also an increase in mortality seen in diabetics 
with HbA1c ≥ 7.5% (Cavero-Redondo et al., 2017), and for every 1% increase in HbA1c, 
the risk for cardiovascular mortality goes up by 5% (Cavero-Redondo et al., 2017). 
T2DM has also been shown to contribute to poor outcomes in patients that develop heart 
disease (Banovic et al., 2016). Leading to the conclusion that HbA1c is a risk factor for 
heart disease and cardiovascular mortality in diabetic patients.  
In African Americans, woman have a greater risk of heart disease than male 
African Americans. Additionally, African American men are 30% more likely to develop 
heart disease than White males (Graham & Garcia, 2012). In 2015, ADA and AHA 
guidelines jointly agreed that practice guidelines be changed. These changes reflect best 
practice guidelines for diabetics and recommend statin therapy in individuals over the age 
of 40 that do not have severe heart disease. Diabetics between 40 and 75 years with 
cholesterol levels ranging from 70-189 mg/dL should also be on medication to control 
CVD (Fox et al., 2015).  
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African Americans are two times more likely to be diagnosed with diabetes than 
non-Hispanic Whites (DHHS, 2016). The rate of diabetes has been shown to be 2-3 times 
higher in the African American population than in whites (Mouton, Hayden, & 
Southerland, 2017; Wenzel & Unger, 2016). In 2009, heart disease killed 46,334 African 
American men, with nearly half of African American adult males, 46%, having some 
form of heart disease (Mouton et al., 2017, p. e38). This group also has a shorter life 
expectancy than their White male counterparts, 74.3 years for White men; 67.2 years for 
African American men (Mouton, et al., 2017, p. e38). Making heart disease a major 
contributor to health disparities in African American mortality (Mouton et al., 2017). 
While there are several risk factors to heart disease in this population, the focus remains 
on the association between HbA1c and heart disease.  
In the African American population, 13.5% of men over the age of 20 years old, 
have diabetes that has been diagnosed by a physician (Mouton et al., 2017). Diabetes then 
leads to vascular complication which leads to a higher mortality rate in African American 
men than in non-Hispanic Whites (Mouton et al., 2017). According to the UKPDS and 
the Diabetes Control and Complications (DCCT) trial, a 1% decrease in diabetic A1c 
reduces the risk of complications by 24% (Kirk et al., 2006; Wenzel & Unger, 2016). 
Socioeconomic Status 
Education 
According to Tull and Roseman (2014), there is an inverse relationship between 
education and income and the rate of diabetes between black and white adults. Yet with 
higher levels of education and income, there is a decrease in the prevalence of chronic 
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disease. In a study based off the National Health Interview Survey dated 1997-2002, 
individuals with less than a high school education were 1.6 times more likely to develop 
chronic disease compared to those with a 4-year college degree (Borrell, Dallo, & White, 
2006; Sacerdote et al., 2012). This leads to the belief that higher educational levels 
promote healthier behaviors and help to identify disease risk (Borrell et al, 2006; 
Sacerdote et al, 2012). There are a limited number of studies that examine education 
levels and prevalence of chronic disease, but no published studies that compare ethnicity 
(Borrell et al, 2006). However, there are studies that have compared heart disease risk 
factors to education and diabetes outcomes which show African Americans are at a 
higher risk for heart disease than whites (Borell et al, 2006). This leads to the belief that 
by improving educational outcomes, the risk of disease could be reduced (Sacerdote et 
al., 2012). Leading to the purpose of comparing educational levels to disease burden 
which is to show a relationship between levels of education and disease prevalence.  
Income 
 
HTN and diabetes have been established as important risk factors for the 
development of heart disease. In most countries, the poorest people have the highest risk 
of developing chronic disease and are the least able to afford medical care (Abegunde, 
Mathers, Adam, Ortegon, & Strong, 2007). One view, on the development of disease, 
focuses on the relationship between socioeconomic levels in lower-income populations 
and the development of disease risk. According to Kim et al, the lower the income level, 
the higher the burden of care becomes financially. Income levels are causes for poverty 
and often chronic disease leads to poverty, lost productivity, and premature death 
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(Geneau, et al., 2010). This research explored the relationship between heart disease 
prevalence and income levels.  
Access to Care  
 
Access to care not only includes affordability, but transportation, the cost of 
prescriptions, lab fees, and office visit charges (Kim, et al., 2016). Defined as a chronic 
disease, diabetes and hypertension receive few financial resources geared towards 
prevention (Geneau, et al., 2010). This research adds to the call for action established by 
the World Health Assembly 2008-2013 Action Plan and the United Nations General 
Assembly meeting in 2011 on chronic disease (Geneau, et al., 2010). With decreased 
access to services those living in lower income areas are at an increased risk for 
premature death and complications from chronic disease (Geneau, et al., 2010). Access to 
care is explored in this research as a confounder to disease burden and focuses on access 
to insurance.  
Rationale for Study  
There have been several studies that focus on HbA1c and cardiovascular disease. 
As early as 1979, data from the Framingham Study was used to measure heart disease in 
diabetics versus nondiabetics (Kannel & McGee, 1979). One of the primary studies on 
heart disease and diabetes is the Action to Control Cardiovascular Risk in Diabetes 
(ACCORD) trial. The purpose of that study was to prevent major heart disease in 
individuals with T2DM. The secondary purpose of that study was to compare current 
practice guidelines with more intensive glycemic control (NIDDK, n.d.). The main goal 
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of the study was to measure major cardiovascular events at onset of diabetes. This 
includes heart attack, stroke, or death from a cardiac event. The study, when complete, 
aims to impact the treatment options and strategies of cardiovascular events in relation to 
diabetic treatments (NIDDK, n.d.).  
Other studies like the ACCORD study include the UKPDS and the Action in 
Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled 
Evaluation (ADVANCE) studies. The UKPDS study found a 21% reduction in 
cardiovascular risk outcomes for every 1% reduction in HbA1c (Kirk et al., 2006). The 
ACCORD study aimed to control hyperglycemia and hypertension. However, the design 
of the ACCORD study and the results of the blood pressure target failed to identify an 
optimal blood pressure range for diabetics. Studies that were conducted after the 
ACCORD and ADVANCE trials are recommending a blood-pressure goal below 130/80 
mm Hg in diabetic patients (Nilsson, 2010).  
The DCCT trial was yet another clinical trial that was conducted from 1983 to 
1993. This study showed that keeping blood glucose as close to normal as possible can 
slow the progression of diseases related to diabetes (NIDDK, n.d.). After the DCCT trial, 
a follow-up study was conducted called the Epidemiology of Diabetes Interventions and 
Complications (EDIC) trial. This trial assesses the incidence and predictors of diabetic 
complications and examines the impact intensive control has on the reduction of heart 
disease risk (NIDDK, n.d.).  
In research conducted by Cederberg et al. (2010), a study on Japanese showed 
that HbA1c of 5.6-6.4% carried a hazard ratio of 13.7 for development of diabetes, this 
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was the first research study conducted to show such a correlation. In addition, this 
research also showed that the risk of heart disease is already increasing prior to high 
glycemic levels in diabetics (Cederberg et al., 2010). This study concluded with the 
finding that HbA1c and 2-hour glucose were associated with heart disease in women, but 
not in men (Cederberg et al., 2010).  
The Multi-Ethnic Study of Atherosclerosis (MESA) follows the Framingham 
Heart Study of 1979, and other studies from the National Heart, Lung, and Blood 
Institute by evaluating non-White race and ethnic groups (Bertoni, Kramer, Watson, & 
Post, 2016; Burke, Lima, Wong, & Narula, 2016). The Framingham Heart Study 
established diabetes as a cardiovascular risk factor (Bertoni et al., 2016). This association 
led to diabetes being labeled as a precursor to coronary heart disease in 2002 showing 
that diabetics have a two-fold risk of developing coronary heart disease with a Hazard 
Ratio of 2.00 and a 95% confidence interval of 1.83 to 2.19 (Bertoni et al., 2016).  
Despite the amount of research conducted on the correlation between diabetes and 
heart disease, more research is needed to show the relation within ethnicities. The 
ACCORD and ADVANCE trials focused on lowering glucose levels to prevent CVD risk 
factors. The results were suggestive of improved outcomes for CVD when HbA1c was 
well controlled. (Skyler et al., 2009) The UKPDS study showed a 15% reduction in heart 
attacks, and a reduction in all-cause mortality after 10 years, with intensive glycemic 
control (Skyler et al., 2009). These studies are suggestive that additional research is 
needed to individualize models of care by population (Skyler et al., 2009). There is still 
much left that is unknown about which diabetic population is greatest at risk despite 
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numerous papers on diabetes and coronary heart disease (Bertoni et al., 2016). Leading to 
the purpose of this research, to establish if HbA1c is a predictor of CVD in the diabetic 
African American population by age group.  
Summary and Conclusion 
There is a lack of focused research to address HbA1c levels and CVD in African 
American men. Several researchers agree that the need exists to identify gaps in care that 
could prevent CVD from developing in those diagnosed with diabetes, while others agree 
that the available data only focuses on white individuals (George et al., 2017). Access to 
medical care also affects disease outcomes as does educational and income levels (Kim et 
al., 2016). These variables are explored to identify additional risk factors related to 
disease progression. This chapter concluded with the identification of the HBM as the 
theoretical foundation for this research. This foundation was used to identify an 
individual’s perceived seriousness of diabetic health threats, and help individuals become 
more proactive in the disease process. In Chapter 3, I will address the research design, the 
rationale for the research, and the review the research questions. The research 




Chapter 3: Methodology 
Introduction 
The purpose of this quantitative study was to assess for an association between 
HbA1c and heart disease in known diabetic African American men. Chapter 3 includes a 
discussion of the research design, the rationale for the research, and the research 
questions. In this study, the independent variable was the HbA1c value, and the 
dependent variable was heart disease. I employed a quantitative approach and used 
multiple logistic regression. The population of this study was diabetic African-American 
men. The sample size was calculated using a G*Power analysis. Data were retrieved from 
the NHANES 2011–2016 survey and variables were pulled and cleaned prior to being 
merged via the Statistical Package for Social Sciences (SPSS) data analysis software. In 
this chapter, I also discuss validity as well as the ethical procedures of this study.      
Research Design and Rationale  
The research design for this project was quantitative, based on the format of the 
NHANES data. For this study, the independent variable was the HbA1c value and the 
dependent variable was heart disease gathered from NHANES data from 2011–2016, 
with the goal being to analyze whether there is a relationship between the given variables 
through statistical analysis (see Grand Canyon University, 2018). The modifier was age, 
and the covariates were education, income, and access to care. I employed multiple 




Research Questions and Hypotheses 
The study addressed the following research questions:  
Research Question 1: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old?  
H01: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
Ha1: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
Research Question 2: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care?  
H02: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care. 
Ha2: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 after controlling for 
education, income, and access to care.  
Methodology 
NHANES is an annual survey collected by the National Center for Health 
Statistics under the CDC (CDC, 2017a). This data is collected to assess the health and 
nutritional status of adults and children within the United States (CDC, 2017a). To ensure 
the reliability of the data, those over the age of 60, African Americans, and Hispanics are 
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oversampled (CDC, 2017a). Each participant is given a thorough examination by a 
licensed physician and includes a dental exam, physical, and lab work (CDC, 2017a).  
The interview is primarily completed in the home of individuals (CDC, 2017a).  Other 
locations include mobile health centers that travel to various locations within the country 
(CDC, 2017a).  Once all exams are completed, the information is entered into a computer 
system where the NHANES data are later generated (CDC, 2017a). Since interviewers 
use electronic devices, they no longer transcribe data, and the threat of incorrect 
transcription has been eliminated (CDC, 2017a).  All information is kept confidential and 
privacy is protected by law (CDC, 2017a).  
After approval from the Walden University IRB, I obtained, analyzed, and 
cleaned the NHANES data to extract only the variables needed for this research. These 
variables included gender, ethnicity, HbA1c values (i.e., glycohemoglobin), age, 
education, income, and access to care. Heart disease encompassed CHD, HTN, high 
cholesterol, heart attack, and stroke. Appendix A shows the variables where the data were 
extracted.  
Once the data were extracted and cleaned, I merged them by sequence number 
into SPSS for analyses. A chi-square analysis was conducted to examine the association 
between HbA1c and heart disease. In addition, a multiple logistic regression was 
conducted to examine the association between HbA1c, heart disease, education, income, 




In this study, I focused on African American men aged 30–64 years old who 
participated in the 2011–2016 NHANES. Since African Americans are more likely to 
develop T2DM than other racial/ethnic groups (Davis et al., 2015), they are at an 
increased risk of developing heart disease. According to the CDC (2017a), across every 
ethnicity, heart disease was either the primary or secondary cause of death in men. Heart 
disease was also the primary cause of death in the African American population (24.1%), 
with diabetes coming in as the sixth leading cause of death (4.6%; CDC, 2017b). Heart 
disease was also the leading cause of death in Whites and American Indians (CDC, 
2017b).  
Sampling and Sampling Procedures 
I drew the sample from the 2011–2016 NHANES data set and focused on diabetic 
African American men aged 30–64 years old. Data were extracted based on age when 
first told they had diabetes, ethnicity, education, family income, access to care, type of 
heart disease, and HbA1c levels (see Appendix A). My inclusion criterion was African-
American men with diabetes between the ages of 30–64 years old. The exclusion criteria 
included those men younger than 30 and over the age of 64, and those with no history of 
diabetes or heart disease. I calculated the sample size via G*power 3.1 and found that a 
minimum sample size of 208 was needed to achieve a power of 0.80 and an odds ratio of 




Participants included in NHANES are randomly selected based on a computer 
algorithm (CDC, 2016). To begin the survey, all counties in the United States are divided 
into 15 groups; each group has specific characteristics (CDC, 2016). One county from 
each group is then selected, and those selected counties are then further divided into 
smaller groups (CDC, 2016).  All homes within these smaller groups are then interviewed 
by trained NHANES interviewers (CDC, 2016).  
To gain approval for use of the data set, I applied and obtained IRB approval from 
Walden University. NHANES data are the most comprehensive public set of data 
available. Other data are from private organizations and require secondary IRB approval, 
making the NHANES data set the ideal choice since it encompasses public data.  
Instrumentation and Operationalization of Constructs 
NHANES is a national survey that was established in 1970 and was built from the 
National Health Survey Act of 1956 (CDC, 2015a). The National Health Survey Act 
created the foundation for the survey and established the sources for NHANES data 
collection to include: individuals to be interviewed, clinical data and locations, and 
medical care facilities (CDC, 2015a). These surveys were then carried out by the 
National Center for Health Statistics (CDC, 2015a).  From these studies, researchers saw 
an emerging pattern that associated disease processes with dietary habits (CDC, 2015a).  
This prompted the development of the NHANES survey, which has been collecting 
annual data on nutrition and health statuses (CDC, 2015a). The survey has since 
developed into the current annual survey, which randomly selects participants from 
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across the United States (CDC, 2015a). All collected data are confidential and voluntary 
(CDC, 2015a). Participants receive a free physical exam and personal interview (CDC, 
2015a).  
NHANES is an annual survey that collects data on chronic conditions and a 
multitude of various ethnicities (CDC, 2015a). This collection of information was 
appropriate for use in this study because the data are from a national survey that has 
established validity and covers the main variables to be addressed. Since this is a 
federally funded study, all laws about privacy and autonomy were followed. I cleaned the 
data and narrowed the variables to the topic at hand.  
Surveys are used to describe the characteristics of a population. In this study, the 
NHANES survey was used to gather information on the health habits and health 
outcomes of individuals. Surveys were developed to help establish trends and to describe 
attitudes, behaviors, and characteristics of a population (Creswell, 2017). Surveys are 
also designed to help identify the beliefs and attitudes of individuals (Creswell, 2017). In 
this survey, health habits and the impact of those habits are being evaluated.  
Reliability of the survey has been established through the repeated usage of the 
survey over time. The results reported are duplicated and follow a systemic pattern. The 
survey is modified and adapted to the changing behaviors and medical conditions of 
participants. Thus, validity is also established as the measurements are obtained, 
analyzed, and published from the intended survey questions. Table 1 addresses the survey 




Table 1  
Exam Questions   
 Exam Question Variable Code  
Q1 Age when first told you have diabetes   DID040 
Q2 Education level – Adults 20+ DMDEDUC2 
Q3 Annual family income INDFMIN2 
Q4 Ever told you had high blood pressure  BPQ020 
Q5 Doctor told you – high cholesterol level (HLD) BPQ080 
Q6 Glycohemoglobin  LBXGH 






Ever told you had a stroke  
Doctor told you, you have diabetes  








Operationalization of Variables 
In this study, the independent variable was the HbA1c value, and the dependent 
variable was heart disease. Abnormal HbA1c levels are defined as blood sugar greater 
than 6.4% in diabetic patients as prediabetes is 5.7%–6.4% (ADA, 2018). HbA1c is 
measured as a percent and assumes a role in the development of heart disease in African 
American men (ADA, 2018). Heart disease was defined as having a history of CHD, 
HTN, high cholesterol, heart attack, or stroke. Demographic variables included age, 
education, income, and access to care.  
I calculated variables using SPPS. The multiple logistic regression test was 
conducted to establish a relationship between the given variables. HbA1c gives the 
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diabetic values to compare to the presence of heart disease, and age allowed the variables 
to be subdivided to compare categories based on the age of diabetes diagnosis and the 
presence of heart disease.  
Data Analysis Plan 
NHANES data were accessed and variables pertinent to the study were extracted. 
The objective was to assess for a correlation between HbA1c and heart disease while 
controlling for age, education, income, and access to care among diabetic African 
American men. Obtained data were cleaned to remove outliers and excess data not 
relevant to the study. Data cleaning was conducted by year and by variables prior to the 
data sets being merged into one SPSS data file. NHANES weights data to account for the 
survey design used during data collection. Each individual surveyed is weighted to 
account for the total number of individuals represented in the survey. When performing 
the data analysis weighting does not need to be readdressed.  
This study is limited to African American males diagnosed with diabetes aged 
30–64 years old. Age 30 was chosen to minimize the chance of including only Type 1 or 
juvenile diabetics, and age 64 was chosen since there is a greater chance of preexisting 
cardiovascular complications by this age. Once data were obtained and merged, only 
diabetic males between 30-64 remained. All other data and missing values were omitted. 
In addition, participants were categorized by age groups and each participant was coded 
by HbA1c levels (Appendix B). All assumptions for multiple logistic regression were 
tested. Data analysis was completed using SPSS Version 21. The dependent variable was 
labeled and measured on a binary scale, and the independent variables were nominal 
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(Lund Research, 2018). The Durbin-Watson was conducted to check for independence of 
observations, and a linear relationship was tested using scatter plots (Lund Research, 
2018). No outliers were identified. Scatter plots also showed the relationship between 
variables (Lund Research, 2018).  
For each age group, a bar chart was shown to represent the levels of HbA1c. In 
addition, descriptive statistics were conducted on each variable. The presentation of the 
findings is from simple to complex (univariate, bivariate, then multivariate). For each of 
the variables, univariate frequencies and percentages are calculated for all categories of 
each variable and displayed. For bivariate comparisons, each of the main variables 
(HbA1c level, education level, income level, and access to care) was compared to 
whether the person has heart disease (yes or no) using chi-square tests plus Phi’s statistics 
to measure the strength of the relationship. For the multivariate analysis, a logistic 
regression model was calculated using heart disease as the dependent variable, HbA1c as 
the primary independent variable and education, income, and access to care as the control 
variables.  
Threats to Validity 
External Validity 
 
External validity can be threatened by misrepresentation. This misrepresentation 
can come from individuals not understanding the questions, the conditions, or the 
language in which the survey is being presented to them. Other threats to external validity 
include the setting in which the survey is administered, treatment interference during the 
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physical examination, low response rates, or high dropout rates. To ensure external 
validity is not affected NHANES workers interview individuals in his/her home, go to the 
individuals in mobile homes, and over-survey to ensure an adequate sample has been 
obtained. Giving the number of years NHANES has collected data, the external validity 
has been addressed. The same results are generalized and remain close to the same year 
after year (Kalaian & Kasim, 2008).  
Internal Validity 
 
Internal validity starts with consistency. NHANES has been consistent with the 
survey and redevelopment of survey’s since it first began in 1970. This type of validity is 
shown when casual relationships can be made between variables (Lavrakas, 2011b). This 
can be validated with NHANES by comparing results survey year to survey year. In this 
current research, results should mirror the NHANES results while also making new 
comparisons. Internal validity was established through history and maturation of the 
questionnaires. Internal validity for this research was established via the instrumentation 
of the survey tool and selection bias is avoided by the randomization of participants based 
on geographical areas (see Lavrakas, 2011b).  
 Construct Validity 
 
The secondary data comes from NHANES surveys which are data used for my 
research. Construct validity cannot be established as NHANES data is nonsequential and 
inferences cannot be made on how data are collected. However, threats may come from 
the wording of the survey and the interpretation of each question (Lavrakas, 2011a). 
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Trained personnel administer the survey to avoid creating construct validity (Lavrakas, 
2011a). 
Ethical Procedures 
The purpose of this research was to assess for a correlation between HbA1c and 
heart disease. After IRB approval, number 08-15-18-0392454, NHANES data were 
accessed and cleaned to obtain the variables of interest for this study. Using SPSS and 
logistic regression the correlation between the variables was evaluated. Participants were 
obtained from secondary data thus there are no risks to participants as identification is 
withheld and information is confidential.  
Participants for this study were obtained via NHANES selection process and 
participation was voluntary. Participants were given the right to withdraw and are aware 
that the information provided is confidential and protected by federal privacy laws. 
Individual participants are given a copy of all medical reports, and individuals were 
helped to identify links between healthy behavior and chronic conditions. This 
information is then made public, so interventions proposals and proactive care can be 
established.  
The data used for this research project is public data. The data collected was 
assessed for how HbA1c factors lead to the development of heart disease in African 
American men. The research was published in ProQuest and thus was available for public 




Summary and Conclusion 
Using a quantitative research design and secondary data from NHANES, a data 
set from 2011-2016 was analyzed. Variables that focused on HbA1c and heart disease 
were extracted and then merged into one SPSS data file. In addition, a data set was 
created to compare multiple types of heart disease in this population. Once imported a 
chi-square analysis and a multiple logistic regression was conducted to assess for a 
correlation between the dependent and independent variables. This information then 
tested the hypothesis to prove if there is a correlation between HbA1c levels and the 
development of heart disease. This chapter concluded with the chi-square analysis and 
multiple logistic regression on the merged data.  In Chapter 4, I will go into detail on the 
data collection process, the coding of the variables in the analysis, and the analysis and 




Chapter 4: Results 
Introduction 
The purpose of this quantitative study was to assess for an association between 
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in 
known diabetic African American men aged 30–64 years old. Covariates included 
education, income, and access to care. In this chapter, I provide the results of the data 
analysis to answer the research questions and to address the research hypotheses. A 
description of the data sets used in the study and the descriptive analysis of the data is 
provided. The inferential statistics used for answering the research questions are also 
summarized.  
Research Questions 
I addressed the following research questions and corresponding hypotheses in this 
study:  
Research Question 1: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old?  
H01: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
Ha1: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old. 
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Research Question 2: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care?  
H02: There is no association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care. 
Ha2: There is an association between HbA1c levels and heart disease in 
African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care.  
Data Collection and Data Set Preparation 
I merged NHANES data from 2011–2016 to establish an adequate number of 
participants for analysis. These data were taken from an annual survey collected by the 
National Center for Health Statistics, under the CDC, and included demographic 
information such as age, gender, and ethnicity. Other questions included: five types of 
heart disease (i.e., CHD, HTN, high cholesterol, heart attack, and stroke); education; 
income; and access to care. Data from each year were cleaned and formatted to align with 
the research questions. I combined data sets using the sequence numbers provided in each 
data set. Missing data and data outside the scope of this study were excluded. The total 
number of participants extracted from this data was N = 243.  
Coding of Variables 
Most variables were not recoded in this data set. I kept the variables in the 
original format in which they were obtained from NHANES. The variable 
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glycohemoglobin was recoded as: 1 for HbA1c less than 6.4 (well controlled), 2 for 
HbA1c 6.5-7.9 (controlled), and 3 for HbA1c > 8 (not controlled; Mayo Clinic, 2019). 
All variables can be found in Appendix B. For heart disease variables (i.e., high 
cholesterol, high blood pressure, CHD, heart attack, and stroke) the number 1 was for yes 
and 2 was for no. Table 2 shows the frequencies for the various types of heart disease.  
Table 2 
Heart Disease Frequencies 
 Yes  No 
High cholesterol 155 88 
High blood pressure 185 58 
Coronary heart disease 21 222 
Heart attack  22 221 
Stroke 25 218 
Descriptive Analysis 
 I generated descriptive statistics based on the number of African American 
diabetic males and their education level, income level, and access to care. Clinical 
characteristics included the type of heart disease, the age of diagnosis, and HbA1c values. 
Education level was categorized into high school graduate, some college or Associates of 
Arts training, and college graduate or above (see Table 3). Annual family income is 
shown in Table 4, and the type of access to care is shown in Table 5, with 91.8% of 
participants having some form of health insurance. Table 4 further indicates multiple 
types of insurance, and an N value greater than 243 is due to an individual having 





  f % 
Education 
level  
High school graduate or less  
Some college or AA 







Note. High school graduate includes those with GED or no diploma. N = 243. 
Table 4 
Annual Family Income  
  f % 
Annual income  0-$9,999                         
$10,000 - $19,999          
$20,000 - $44,999         
$45,000 – $74,999        
$75,000-$99,999           













Missing   9 3.9 




Access to Care  
  f % 
Covered by health insurance   223 91.8 
Not covered by insurance    20 8.2 
Types of insurance     
Covered by private insurance  Private insurance     





Covered by government 
insurance  
Medicare 
Military health care 







Covered by state insurance  Medicaid 






Types of heart disease are classified in Table 6. Those with high blood pressure 
accounted for 76.1% of total participants, while those with high cholesterol totaled 63.8% 
of participants. In addition, those with high cholesterol and high blood pressure 
accounted for 39.1% of total participants. A large proportion of participants were 
diagnosed with diabetes between the ages of 40–49 years of age (see Table 7), and those 




Type of Heart Disease 
 f % 




High blood pressure 185 76.1 
Coronary heart disease 21 8.6 
Heart attack  22 9.1 
Stroke 25 10.3 
 
Multiple heart diseases 
  
High cholesterol & high blood pressure  95 39.1 
High cholesterol, high blood pressure, & stroke 8 3.3 
High cholesterol, high blood pressure, & heart attack  6 2.5 
High cholesterol, high blood pressure, & coronary heart disease  6 2.5 
High blood pressure & stroke 5 2.1  
High cholesterol, high blood pressure, coronary heart disease, & heart attack  4 1.6 
High blood pressure & heart attack  3 1.2 
High cholesterol, high blood pressure, heart attack, & stroke  3 1.2 
High cholesterol, high blood pressure, coronary artery disease, & stroke 2 .8 
High blood pressure & coronary heart disease   2 .8 
Other forms of mixed heart disease  8 3.2 
No form of heart disease  24 9.9 





Age When Participant First Told They had Diabetes  
 Age in years f % 















Missing  20 8.2 
Note. Data were categorized from original data.  
Table 8 
HbA1c Level  
 HbA1c range f % 
Glycohemoglobin Level (HbA1c) 4.5 – 6.4  
6.5 – 7.9  







Note. Data were categorized from original data.  
Description of the Study Sample 
The study population was representative of 243 adult, African American, diabetic 
males. The sample was drawn from NHANES 2011–2016 data. The average participant 
(54.7%) had a high school education or less, earned $20,000–$44,999 (29.1%), and had 
insurance (91.8%). Of those that had insurance, 57.7% had government insurance either 
through Medicare, military health care, or other forms of government insurance. The 
remaining participants had some college or an associate degree (26.7%) or were 
considered a college graduate (18.5%). The distribution of HbA1c values ranged from 
4.5–16.5. This distribution is shown below in Figure 1.  
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Figure 1. Distrubution of HbA1c values.   
 Figure 1 shows the distribution of HbA1c to be skewed to the left. While the 
average HbA1c was 7.6%, the lowest reported value was 4.5% and the highest reported 
value was 16.5%. Of that population, 73 had an HbA1c of less than 6.4 (i.e., well 
controlled), 98 had an HbA1c from 6.5%–7.9% (i.e., controlled), and 72 had an HbA1c 
of > 8% (i.e., not controlled). The histogram of age at the time of diagnosis is slightly 





Figure 2. Age of diabetes diagnosis.  
Chi-Square Analysis – Research Question 1 
With Research Question 1, I asked: Is there an association between HbA1c levels 
and heart disease in African American men with diabetes aged 30–64 years old? Chi-
square analysis was run to compare the association between heart disease and HbA1c 
values. No association was found between heart disease and HbA1c values; therefore, I 
failed to reject the null hypothesis. There is no association between HbA1c levels and 
heart disease in African American men with diabetes aged 30–64 years old. 
To determine this, I conducted a chi-square test for association between high 
blood pressure and HbA1c. Statistical assumptions were tested and met. In addition, all 
expected frequencies were greater than five. There was no statistically significant 
association found between high blood pressure and HbA1c x2(2) = 1.085, p = .581. Chi-
square was then conducted on high cholesterol levels and HbA1c. All expected 
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frequencies were greater than five and there was no statistical significance found x2(2) = 
1.763, p = .414. The chi-square between CHD and HbA1c was conducted with all 
frequencies being greater than five. No statistical significance was found x2(2) = 2.799, p 
= .247. I also conducted chi-square analysis on heart attack and HbA1c and found all 
expected frequencies were greater than five and no statistical significance x2(2) = .526, p 
= .769. Chi-square analysis was conducted on stroke and HbA1c. All expected 
frequencies were greater than five, and no statistical significance was found between 
stroke and HbA1c x2(2) = .484, p = .785. Lastly, I conducted chi-square analysis on high 
cholesterol and high blood pressure and found all expected frequencies were greater than 
five and no statistical significance x2(2) = .850, p = .654. Table 9 shows the outcome for 




Chi-Square Analysis  
Pearson’s Chi-square Chi-square df p value Phi 
Ever told you have high blood pressure 1.085 2 .581 .067 
Doctor told you high cholesterol 1.763 2 .414 .085 
Ever told you had coronary heart disease  .2799 2 .247 .107 
Ever told you had heart attack  .526 2 .769 .047 
Ever told you had a stroke .484 2 .785 .045 
High cholesterol & high blood pressure .850 2 .654 .059 
Note. Association between HbA1c and heart disease. 
Multiple Logistic Regression – Research Question #2 
 With Research Question 2, I asked: Is there an association between HbA1c levels 
and heart disease in African American men with diabetes aged 30-64, after controlling for 
education, income and access to care? Multiple logistic regression was conducted to 
compare the association between heart disease, HbA1c, education, income, and access to 
care among diabetic African American men age 30-64.  
 Multiple logistic regression was performed to determine the effects of education, 
income, and access to care on the likelihood that HbA1c levels would contribute to high 
blood pressure in the male African American population aged 30-64. Assumptions were 
tested and there is a linear relationship between the continuous independent variable and 
transformation of the dependent variable, the data does not have multicollinearity, and 
there were no significant outliers.  
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The logistic regression model was not statistically significant, x2(4) = 3.363, 
p=.515. The model explained 2.1% (Nagelkerke R2) of the variance in high blood 
pressure and correctly classified 76.1% of the cases. Of the predictor variables, none were 
statistically significant as seen in Table 10. Therefore, we reject the alternative hypothesis 
and accept the null hypothesis. There is no association between HbA1c levels and heart 
disease (high blood pressure) in African American men with diabetes aged 30-64, after 
controlling for education, income and access to care. 
Table 10 
High Blood Pressure, Education, Income, Access to Care, and HbA1c   
 




Step 1a Education level - 
Adults 20+ 
.108 .134 .650 1 .420 1.114 .857 1.447 
Annual family 
income 
-.070 .040 3.114 1 .078 .932 .862 1.008 
Covered by health 
insurance 
.040 .548 .005 1 .942 1.041 .356 3.045 
Glycohemoglobin .028 .196 .020 1 .887 1.028 .700 1.510 
Constant -1.085 .873 1.543 1 .214 .338   
 
*Note. Logistic Regression Predicting Likelihood of High Blood Pressure based on Education, Income, 
Access to Care, and Glycohemoglobin.  a. Variable(s) entered on step 1: Education level - Adults 20+, 
Annual family income, Covered by health insurance, Glycohemoglobin. 
Multiple logistic regression was performed to determine the effects of education, 
income, and access to care on the likelihood that HbA1c levels would contribute to high 
cholesterol in the male African American population aged 30-64. The logistic regression 
model was not statistically significant, x2(4) = 1.961, p=.743. The model explained 1.1% 
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(Nagelkerke R2) of the variance in high cholesterol and correctly classified 63.8% of the 
cases. Of the predictor variables, none were statistically significant as seen in Table 11. 
There is no association between HbA1c levels and heart disease (high cholesterol) in 
African American men with diabetes aged 30-64, after controlling for education, income 
and access to care. 
Table 11 
High Cholesterol, Education, Income, Access to Care, and HbA1c 






Education level - 
Adults 20+ 
-.003 .117 .001 1 .976 .997 .793 1.252 
Annual family 
income 
-.011 .034 .101 1 .751 .989 .926 1.057 
Covered by health 
insurance 
.131 .482 .074 1 .786 1.140 .443 2.929 
Glycohemoglobin -.224 .174 1.655 1 .198 .799 .568 1.125 
Constant -.170 .769 .049 1 .825 .844   
*Note. Logistic Regression Predicting Likelihood of High Cholesterol based on Education, Income, Access 
to Care, and Glycohemoglobin. a Variable(s) entered on step 1: Education level - Adults 20+, Annual 
family income, Covered by health insurance, Glycohemoglobin. 
Multiple logistic regression was performed to determine the effects of education, 
income, and access to care on the likelihood that HbA1c levels would contribute to 
coronary heart disease in the male African American population aged 30-64. The logistic 
regression model was not statistically significant, x2(4) = 1.460, p= .834. The model 
explained 1.3% (Nagelkerke R2) of the variance in coronary heart disease and correctly 
classified 91.4% of the cases. Of the predictor variables, none were statistically 
significant as seen in Table 12. Therefore, we fail to reject the null hypothesis. There is 
no association between HbA1c levels and heart disease (coronary heart disease) in 
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African American men with diabetes aged 30-64, after controlling for education, income 
and access to care.  
Table 12 
Coronary Heart Disease, Education, Income, Access to Care, and HbA1c  






Education level - 
Adults 20+ 
.050 .201 .062 1 .803 1.051 .709 1.558 
Annual family 
income 
.045 .061 .547 1 .459 1.046 .928 1.179 
Covered by health 
insurance 
.664 1.056 .396 1 .529 1.943 .245 15.389 
Glycohemoglobin -.092 .296 .096 1 .757 .912 .511 1.630 
Constant 1.343 1.457 .850 1 .357 3.830   
*Note. Logistic Regression Predicting Likelihood of Coronary Heart Disease based on Education, Income, 
Access to Care, and Glycohemoglobin. a. Variable(s) entered on step 1: Education level - Adults 20+, 
Annual family income, Covered by health insurance, Glycohemoglobin. 
Multiple logistic regression was performed to determine the effects of education, 
income, and access to care on the likelihood that HbA1c levels would contribute to a 
heart attack in the male African American population aged 30-64. The logistic regression 
model was not statistically significant, x2(4) = 6.326, p=.176. The model explained 5.6% 
(Nagelkerke R2) of the variance in heart attack and correctly classified 90.9% of the 
cases. Of the predictor variables, none were statistically significant as seen in Table 13. 
Therefore, we accept the null hypothesis. There is no association between HbA1c levels 
and heart disease (heart attack) in African American men with diabetes aged 30-64, after 




Heart Attack, Education, Income, Access to Care, and HbA1c  






Education level - 
Adults 20+ 
.352 .198 3.147 1 .076 1.422 .964 2.098 
Annual family 
income 
.038 .062 .375 1 .540 1.039 .920 1.173 
Covered by health 
insurance 
.804 1.061 .575 1 .448 2.235 .280 17.871 
Glycohemoglobin -.167 .292 .327 1 .567 .846 .477 1.500 
Constant .465 1.420 .107 1 .744 1.592   
 
*Note. Logistic Regression Predicting Likelihood of Heart Attack based on Education, Income, Access to 
Care, and Glycohemoglobin. a Variable(s) entered on step 1: Education level - Adults 20+, Annual family 
income, Covered by health insurance, Glycohemoglobin. 
Multiple logistic regression was performed to determine the effects of education, 
income, and access to care on the likelihood that HbA1c levels would contribute to stroke 
in the male African American population aged 30-64. The logistic regression model was 
statistically significant, x2(4) = 10.186, p=.037. The model explained 8.5% (Nagelkerke 
R2) of the variance in stroke and correctly classified 89.7% of the cases. Of the predictor 
variables income was statistically significant (p=.036). However, the glycohemoglobin 
level is no significant (p=.567). Increased income was not associated with an increased 
likelihood of stroke as seen in Table 14. Therefore, we fail to reject the null hypothesis. 
There is no association between HbA1c levels and heart disease (stroke) in African 




Stroke, Education, Income, Access to Care, HbA1c  






Education level - 
Adults 20+ 
.222 .185 1.442 1 .230 1.249 .869 1.796 
Annual family 
income 
.135 .064 4.394 1 .036 1.145 1.009 1.299 
Covered by health 
insurance 
.176 .791 .050 1 .823 1.193 .253 5.620 
Glycohemoglobin .130 .276 .223 1 .637 1.139 .663 1.957 
Constant .151 1.189 .016 1 .899 1.163 
  
 
*Note.  Logistic Regression Predicting Likelihood of Stroke based on Education, Income, Access to Care, 
and Glycohemoglobin a. Variable(s) entered on step 1: Education level - Adults 20+, Annual family 
income, Covered by health insurance, Glycohemoglobin. 
Summary and Conclusion  
This chapter concluded with the results of the data analysis for heart disease and 
HbA1c in African American men age 30-64. This study was conducted with NHANES 
data from 2011-2016, and missing data were excluded from this study. For Research 
Question #1 a chi-square analysis was conducted. All assumptions were tested and met. 
This concluded that there is no statically significant association between heart disease and 
HbA1c in this population. Multiple logistic regression was conducted for Research 
Question #2. This tested for an association between heart disease, HbA1c, education, 
income, and access to care. The analysis concluded that there is no association between 
HbA1c levels, education, income, and access to care. The strengths and limitations of this 
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study were discussed and recommendations for future research were explored. Chapter 5 
will give an interpretation of the study results presented in this chapter based on the 
theory of this study. Chapter 5 will also explore social change and give a final overview 





Chapter 5: Discussions, Conclusions, and Recommendations  
Introduction 
The purpose of this quantitative study was to assess for an association between 
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in 
known diabetic, African American men aged 30–64 years old. The covariates were 
education, income, and access to care. In this chapter, I discuss the results, study 
limitations, and implications for social change.  In addition, recommendations for future 
research and concluding ideas about the findings of the study are provided. Whiteley et 
al. (2005) suggested that diabetes risk factors be treated as aggressively as heart disease 
risk factors. While there is some ethnicity-based research on the relationship between 
diabetes and heart disease in the field, there are limited published data by ethnicity.  
African Americans are 2 times more likely to be diagnosed with diabetes than 
non-Hispanic Whites (DHHS, 2016). Further research in 2010 corroborated these 
findings and added that in the ADA’s view, evidence exists to support an association with 
higher HbA1c levels and heart disease (Matsushita et al., 2010; Selvin et al., 2010). I 
aimed to add to the knowledge in the field by analyzing secondary NHANES data from 
2011–2016. I developed the following research questions to guide this study: 
 
Research Question 1: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old? 
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Research Question 2: Is there an association between HbA1c levels and heart 
disease in African American men with diabetes aged 30–64 years old after 
controlling for education, income, and access to care?  
I conducted the study using chi-square analysis and multiple logistic regression. 
Findings from this study showed that there is no significant relationship between any of 
the covariates tested. However, the significance of income and high blood pressure (p = 
.078), education and heart attack (p = .076), or income and stroke (p = .036) are 
questioned given the small sample size of these populations (see Table 15). Overall, there 
were no significant findings between heart disease and HbA1c values in this population. 
Table 15 
Summary of Findings 
 B S.E. Wald df Sig. Exp(B) 




Education level - 
adults 20+ 






-.070 .040 3.114 1 .078 .932 .862 1.008 
Stroke Annual family 
income 
.135 .064 4.394 1 .036 1.145 1.009 1.299 
Note. HbA1c, heart disease, education, and income levels.  
Interpretation of the Findings 
 The AHA and the ADA agree that lifestyle and medical interventions can delay 
or reduce the development of heart disease (Buse et al., 2007). According to Babikr et al. 
(2016), studies in adults have shown that early diabetic interventions reduce 
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cardiovascular complications and mortality. Yet, African Americans are not receiving 
recommended treatments (Vulic et al., 2010). 
I conducted a chi-square analysis to test Research Question1. The chi-square 
analysis showed no association between heart disease and HbA1c levels. For Research 
Question 2, the multiple logistic regression showed no association between heart disease, 
HbA1c levels, education, income, and access to care.  
One possible reason for the lack of significance in heart disease and HbA1c is due 
to the sample size of the population that reported having heart disease. While the total 
number of participants was enough for this study, each type of heart disease needs to 
encompass a larger sample size. The total N value for each type of participant is seen in 
Table 6. With more participants, the outcome of the analysis could change.  
Another possible reason for this outcome is the natural progression of the disease. 
Diabetes often leads to vascular complications, which manifest in the kidneys first 
(Mouton et al., 2017). This damage to the kidneys then causes high blood pressure and 
subsequent heart disease (NIDDK, 2017). My findings in the literature review confirmed 
that kidney disease is an issue in African Americans. Diabetic African Americans have a 
46% higher chance of developing kidney disease and kidney failure resulting in dialysis 
than non-Hispanic Whites (Kirk et al., 2006). African Americans also have a higher 
prevalence of chronic conditions to include heart disease and stroke (Thorpe Jr. et al., 
2017).  
The HBM, used as the theoretical framework in this study, allows for intervention 
measures and education to be provided to this population. In addition, the belief of how 
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the disease progresses and is treated can be incorporated into lifestyle changes based on 
the risk factors identified in the results. My recommendation is for further research on the 
association between kidney disease and heart disease or kidney disease and HbA1c levels 
in this diabetic population.  
Limitations of the Study 
The limitations of this study came from the use of secondary data. Bias can come 
from several sources and include the researcher, lack of authenticity, and outdated study 
methods (Revise Sociology, 2017). The main limitation was missing data from the 
dependent variables. No explanation was given as to why data were missing, but it can be 
assumed that a participant left the question blank during the survey.  
Other limitations came from the data sets. Individual data sets did not allow for an 
adequate number of participants. This required the merging of additional data sets until 
an adequate sample size could be obtained. I added the most recent year (2015–2016) and 
the previous year’s data (2011–2012) to the data set being analyzed. Each data set was 
cleaned and included male, diabetic individuals over the age of 29 and under the age of 
65. This significantly reduced the number of eligible participants. Again, the lack of an 
adequate sample size for each individual type of heart disease may have affected the 
results of this study.  
As stated in Chapter 1, another study limitation came from the inability to identify 
the type of diabetes a participant has. To eliminate Type 1 diabetics, participants were 
limited to those over 30 years of age. However, this created the potential to miss Type 2 
diabetics under 30, which includes both adults and children.  
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In addition, limitations were put on how HbA1c data was obtained. I conducted 
the initial analysis using self-reported HbA1c levels, which significantly reduced the 
available number of participants, thus the HbA1c level was replaced with a collected lab 
value (i.e., glycohemoglobin) to increase the number of participants in the analysis. 
Additionally, to analyze the various types of heart disease, I created a data set to merge 
heart disease types. This allowed for individuals with multiple forms of heart disease to 
be identified and analyzed.  
Recommendations 
African Americans have similar rates of high cholesterol as Whites, and they also 
tend to have high blood pressure related to renal disease (DHHS, 2016). According to the 
DHHS, Office of Minority Health, this population is twice as likely to develop diabetes 
and suffer from end-stage renal disease (DHHS, 2016). In 2008, 461.7 per 100,000 
individuals were diagnosed with end-stage renal disease (CDC, 2016).  
I conducted this study using NHANES data from 2011–2016 to examine the 
association between HbA1c and heart disease in African American men aged 30–64 years 
old. In addition, the association between HbA1c, heart disease, education, income and 
access to care was also evaluated using multiple logistic regression. There are a limited 
number of extant research studies that focused on ethnicity in relation to diabetes and 
heart disease (Raj, Bhatti, Badada, & Ramteke, 2015). I would recommend that this study 
be expanded to include the association between kidney disease, HbA1c, heart disease, 
and multiple ethnicities and genders. I would also expand this study into other areas of 
data collection, such as the NIDDK as well as organizations from the private and public 
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sectors. While NHANES is all-encompassing, the data collected are randomized, 
controlled data that are geographical, thus expanding into other areas may provide 
different results.  
Additionally, future research could explore the effectiveness of diabetic 
prevention programs for those at higher risk of heart disease based on HbA1c values. The 
ADA agrees that lifestyle and medical interventions can delay or reduce the development 
of heart disease, allowing diabetics to live longer, healthier lives (Buse et al., 2007). 
While access to care did not prove to be a confounder, patient outcomes are affected by 
income levels. Therefore, programs should focus on the needs of each individual 
population and not just the entire population as one.  
Implications 
According to Walden University (2017), social change is working to better foster 
social change “through research, projects, community engagement, and the education of 
scholar-practitioners” (Walden University, 2018, para 3). The social change implications 
of this study are influenced by socioeconomic factors, such as income and education, and 
are predictors of high blood pressure, heart attack, and stroke in diabetic African 
American men. Therefore, diabetic control and prevention programs need to account for 
these factors.  
While social change is designed to help individuals within a community, having 
the necessary resources to assist this population must first be identified and established. 
Understanding the characteristics of a diabetes diagnosis is essential to establishing 
therapeutic goals to prevent CVD. As part of Walden Universities 2020 plan for social 
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change, this can help to create “a positive impact on society and create benefits for the 
public” (Walden University, 2017, p.7). This is established by educating individuals on 
diabetic outcomes and the prevention of diabetic complications such as heart disease. 
When individuals are given the information needed to make informed health care 
decisions, ownership is established. With ownership comes control of the disease and 
improved lifestyle and disease management.  
In part of the literature review, I focused on an algorithm for disease management. 
This information can be added to that literature as part of the education needed to make 
an informed decision on the lifestyle an individual chooses to maintain control of the 
disease process. While the results of this study did not clearly prove the correlation 
between heart disease and HbA1c levels, the literature shows that more research is 
needed. This additional research could help to identify potential disparities in HbA1c 
values and the development of heart disease (Jeppesen et al., 1998; Traylor et al., 2010). 
In addition, this research will help individuals to understand the relationship between 
high blood sugars (i.e., HbA1c) and heart disease (George et al., 2017). 
Conclusion 
To manage disease, a person must be aware of the consequences of not managing 
the disease. When speaking about diabetes this can include heart disease, renal disease, 
blindness, and even death (CDC, 2016). I conducted this study to show the association 
between HbA1c and heart disease, and while the results failed to show that association, 
one may exist in other ethnicities and genders. There is ample data to support an 
association between heart disease and HbA1c in White individuals, but there remains a 
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lack of research on this topic in other ethnicities. With this study, I addressed the gap in 
the literature that exists for this population but no other ethnicities.  
While the findings of this study failed to demonstrate an association between 
HbA1c and heart disease, using a larger population may change that outcome. In 
addition, though no statistical significance was found between education and heart attack 
or income and high blood pressure, the risk is still present, and the results should not be 
discounted. The use of HBM ties in education to prevention, and with better education, 
diabetic outcomes can be improved.  
Proper management of diabetes can lead to an improvement in the overall health 
and well-being of diabetic individuals. However, future research is needed to establish 
whether renal disease is a factor to consider in the development of heart disease of 
diabetic African American males. Research has shown that heart disease is most 
prevalent in the African American community, and African Americans are more likely to 
have diabetes than Whites (DHHS, 2016). They are also 4.2 times more likely to develop 
renal disease from diabetes (DHHS, 2016). Therefore, a larger sample should be obtained 
from other sources to better assess the outcome. A study should be conducted on HbA1c, 
heart disease, and renal disease to establish whether adverse outcomes exist in this 
population to provide stronger evidence to link HbA1c levels to heart disease in African 
American men and create a proactive culture to treat those at the greatest risk from 
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Appendix A: Table of the Variables Imported From Each File 





Ever told you had high blood pressure 





Doctor told you have diabetes 






Ever told you had coronary heart disease  
Ever told you had heart attack  







INDFMIN2   
Gender 
Age in years at screening  
Race/Hispanic origin  
Education level – Adults 20+  












Covered by health insurance  
Covered by Private Insurance  
Covered by Medicare  
Covered by Medicaid  
Covered by state-sponsored health plan 
Covered by other Government Insurance   
Covered by single service plan  
No Coverage of any type  
Covered by military health care  
GHB_H 
 




Appendix B: Coding of Variables  
Variable Common Name Original Categories New Categories 
DID040 
 
Age when first 
told you had 
diabetes 

















10. Over 14.1 
DMDEDUC2 
 
Education Level 1. Less than 9th Grade 
2. 9-11th Grade 
(including 12th with 
no diploma) 
3. High School Graduate 
or GED 
4. Some College or AA 
























12. 20000 and over 

















All other - 999 
HIQ_ Access to Care 1. Covered by health 
insurance  
2. Covered by Private 
Insurance  
3. Covered by Medicare  
4. Covered by Medicaid  
5. Covered by state-
sponsored health plan 




7. Covered by single 
service plan  
8. No Coverage of any 
type  
9. Covered by military 
health care 




3. State Sponsored 
(4/5) 
4. No Coverage (8) 
 
